Back to Newslist February 04 | 2019
Vectron receives Fab grant from NFR

To build on exciting results and to further develop Vectron's expression technology platform for cost-efficient and robust production of Fabs and other antibody fragments, Vectron has received a substantial research grant from the Norwegian Research Council. The objective is to develop an expression platform that consistently result in >10 g/L of soluble Fabs. SINTEF will be project partner and utilize their extensive experience with fed-batch fermentation to help develop Fab production processes. The planned project is expected to start in the summer of 2019 and continue for four years.